John Cobb - Ventas Executive Vice President, Chief Investment Officer
| VTR Stock | USD 42.36 0.13 0.31% |
President
Mr. John D. Cobb is Executive Vice President, Chief Investment Officer of Ventas, Inc. Mr. Cobb was our Executive Vice President, Chief Investment Officer since March 2013, after serving as our Senior Vice President, Chief Investment Officer from 2010 to March 2013. Prior to that, Mr. Cobb was a President and Chief Executive Officer of Senior Lifestyle Corporationrationration, where he led the strategic direction of a 9, 000 unit retirement company with over 3, 400 employees. Prior to that, he held various positions with GE Healthcare Financial Services, a division of General Electric Capital Corporationrationration, which is a subsidiary of General Electric Corporationrationration, with the last being Senior Managing Director, where he led a team focused on debt and equity investments in healthcare real estate totaling over 9 billion. Mr. Cobb has served as a member of the Board of Directors of the National Investment Center for the Seniors Housing Care Industry. He is currently a member of the Executive Board of the American Seniors Housing Association. since 2013.
| Age | 53 |
| Tenure | 11 years |
| Address | 353 North Clark Street, Chicago, IL, United States, 60654-4708 |
| Phone | 877 483 6827 |
| Web | https://www.ventasreit.com |
Ventas Management Efficiency
The company has Return on Asset of 0.0165 % which means that on every $100 spent on assets, it made $0.0165 of profit. This is way below average. Ventas' management efficiency ratios could be used to measure how well Ventas manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/18/2024, Return On Tangible Assets is likely to grow to -0.0018. In addition to that, Return On Capital Employed is likely to drop to 0.03. At this time, Ventas' Non Current Assets Total are relatively stable compared to the past year. As of 04/18/2024, Other Assets is likely to grow to about 25.1 B, though Non Currrent Assets Other are likely to grow to (819.6 M).Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Christopher Douglas | Healthcare Realty Trust | 42 | |
| Robert Hull | Healthcare Realty Trust | 52 | |
| D Mendelsohn | National Health Investors | 59 | |
| Daniel Klein | Healthpeak Properties | 56 | |
| Mark Kennedy | Global Medical REIT | N/A | |
| Talya NevoHacohen | Sabra Healthcare REIT | 64 | |
| John Bryant | Healthcare Realty Trust | 57 | |
| John Spaid | National Health Investors | 64 | |
| Del Taylor | Healthpeak Properties | 67 | |
| Bradley Page | Healthpeak Properties | 60 | |
| J Douglas | Healthcare Realty Trust | 45 | |
| Laurie Becker | Healthpeak Properties | 44 | |
| Allen Webb | Global Medical REIT | 50 | |
| Cheryl Ramagano | Universal Health Realty | 61 | |
| Jeffrey Theiler | Healthpeak Properties | 50 | |
| Jeff Theiler | Healthpeak Properties | 46 | |
| Douglas Whitman | Healthcare Realty Trust | 48 | |
| Charles Boyle | Universal Health Realty | 64 | |
| Mark Theine | Healthpeak Properties | 41 | |
| Timothy Fowler | Universal Health Realty | 69 | |
Management Performance
| Return On Equity | -0.003 | ||||
| Return On Asset | 0.0165 |
Ventas Inc Leadership Team
Elected by the shareholders, the Ventas' board of directors comprises two types of representatives: Ventas inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ventas. The board's role is to monitor Ventas' management team and ensure that shareholders' interests are well served. Ventas' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ventas' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Edmund III, Chief VP | ||
| T Riney, Executive Vice President Chief Administrative Officer, General Counsel, Secretary, Ethics and Compliance Officer | ||
| Carey JD, General VP | ||
| Jay Gellert, Independent Director | ||
| Richard JD, Senior Advisor | ||
| Maurice Smith, Independent Director | ||
| Douglas Pasquale, Director | ||
| Richard Gilchrist, Independent Director | ||
| Louise Adhikari, VP Communications | ||
| Ryan Shannon, IR Contact Officer | ||
| Robert Probst, Chief Financial Officer, Executive Vice President | ||
| J Hutchens, Executive Vice President - Senior Housing | ||
| Roxanne Martino, Independent Director | ||
| Juan Sanabria, Vice President of Investor Relations | ||
| Justin Hutchens, Executive Officer | ||
| Douglas Crocker, Presiding Independent Director | ||
| Glenn Rufrano, Independent Director | ||
| Randy Sohanaki, Vice President - IT Applications | ||
| Julie Robinson, Senior Investments | ||
| Brian Wood, Chief VP | ||
| John Cobb, Executive Vice President, Chief Investment Officer | ||
| Peter Bulgarelli, Executive Vice President and President and Chief Executive Officer, Lillibridge Healthcare Services, Inc. | ||
| Richard Riney, Chief Admin. Officer, Executive VP and General Counsel | ||
| Bhavana Devulapally, Senior Vice President, Chief Information Officer | ||
| Michael Embler, Independent Director | ||
| Walter Rakowich, Independent Director | ||
| Debra Cafaro, Chairman of the Board, Chief Executive Officer | ||
| Gregory Liebbe, Senior Vice President Chief Accounting Officer, Controller | ||
| Robert Reed, Independent Director | ||
| Timothy Sanders, Senior Investment Officer | ||
| Christian Cummings, Senior Housing | ||
| Melody Barnes, Independent Director | ||
| James Shelton, Presiding Independent Director | ||
| Todd Lillibridge, Executive VP of Medical Property Operations, CEO of Lillibridge Healthcare Services Inc and President of Lillibridge Healthcare Services Inc | ||
| Matthew Lustig, Independent Director | ||
| Sean Nolan, Independent Director | ||
| Carey Roberts, Executive Vice President General Counsel and Ethics & Compliance Officer | ||
| Marguerite Nader, Independent Director |
Ventas Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ventas a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.003 | ||||
| Return On Asset | 0.0165 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 30.54 B | ||||
| Shares Outstanding | 404.05 M | ||||
| Shares Owned By Insiders | 0.58 % | ||||
| Shares Owned By Institutions | 96.11 % | ||||
| Number Of Shares Shorted | 6.35 M | ||||
| Price To Earning | 909.80 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ventas Inc is a strong investment it is important to analyze Ventas' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Ventas' future performance. For an informed investment choice regarding Ventas Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Ventas Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Ventas Stock analysis
When running Ventas' price analysis, check to measure Ventas' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventas is operating at the current time. Most of Ventas' value examination focuses on studying past and present price action to predict the probability of Ventas' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventas' price. Additionally, you may evaluate how the addition of Ventas to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Ventas' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ventas. If investors know Ventas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ventas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.59) | Dividend Share 1.8 | Earnings Share (0.08) | Revenue Per Share 11.199 | Quarterly Revenue Growth 0.135 |
The market value of Ventas Inc is measured differently than its book value, which is the value of Ventas that is recorded on the company's balance sheet. Investors also form their own opinion of Ventas' value that differs from its market value or its book value, called intrinsic value, which is Ventas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ventas' market value can be influenced by many factors that don't directly affect Ventas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ventas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ventas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ventas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.